Comparing lycopene's impact on mortality in adults with or without obesity

Xiaorong Han,Jinxing Liu,Yingzhen Gu,Yifan Li,Wei Zhang,Naqiang Lv,Aimin Dang
DOI: https://doi.org/10.1039/d3fo04533a
IF: 6.3173
2024-03-12
Food & Function
Abstract:Objective : Given lycopene's anti-inflammatory and antioxidant properties, we investigated its mortality impact in individuals with and without obesity, confirming distinct effects. Methods : This study analyzes the National Health and Nutrition Examination Survey (NHANES) data from 2003–2006 and 2017–2018, linking lycopene levels to all-cause and cardiovascular mortality. Using various statistical methods, three models are sequentially adjusted for confounders, investigating the lycopene-outcome relationship. Results : We studied 11 737 adults for 162 months and found 1537 all-cause deaths (13.1%) and 443 cardiovascular deaths (3.8%). For those without obesity, serum lycopene had an "L" shape relationship with all-cause mortality, being harmful at very low levels but protective above a certain threshold. It consistently protects against cardiovascular mortality. In individuals with obesity, the relationship with all-cause mortality formed a "U" shape, with increased risk at very low and very high lycopene levels and protection in the middle range. Cardiovascular mortality showed a similar pattern in individuals with obesity. Interestingly, dietary lycopene intake had protective effects in both groups. Conclusion : This study reveals that lycopene exhibits distinct associations with all-cause and cardiovascular mortality in populations with or without obesity, emphasizing the importance of considering individual health profiles when assessing its benefits.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?